X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
female (12) 12
male (12) 12
middle aged (12) 12
index medicus (11) 11
aged (10) 10
abridged index medicus (9) 9
double-blind method (9) 9
treatment outcome (9) 9
drug therapy (8) 8
drug therapy, combination (8) 8
clopidogrel (7) 7
medicine, general & internal (7) 7
myocardial infarction (7) 7
risk factors (7) 7
stroke (7) 7
acute coronary syndrome - drug therapy (6) 6
acute coronary syndromes (6) 6
aspirin (6) 6
patient outcomes (6) 6
cardiovascular diseases - prevention & control (5) 5
heart attacks (5) 5
kaplan-meier estimate (5) 5
patients (5) 5
risk (5) 5
ticlopidine - analogs & derivatives (5) 5
anticholesteremic agents - adverse effects (4) 4
anticholesteremic agents - therapeutic use (4) 4
cardiac & cardiovascular systems (4) 4
cardiovascular disease (4) 4
cerebral infarction (4) 4
cholesterol, ldl - blood (4) 4
clinical outcomes (4) 4
follow-up studies (4) 4
acute coronary syndrome (3) 3
acute coronary syndrome - mortality (3) 3
aspirin - therapeutic use (3) 3
atrial fibrillation (3) 3
blood platelets (3) 3
cardiology (3) 3
cardiovascular diseases (3) 3
cardiovascular diseases - drug therapy (3) 3
cardiovascular diseases - mortality (3) 3
care and treatment (3) 3
cholesterol (3) 3
coronary heart disease (3) 3
dosage and administration (3) 3
drug dosages (3) 3
health aspects (3) 3
health risk assessment (3) 3
hemorrhage - chemically induced (3) 3
ischemia (3) 3
low density lipoprotein (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
myocardial infarction - drug therapy (3) 3
myocardial-infarction (3) 3
platelet aggregation inhibitors - adverse effects (3) 3
platelet aggregation inhibitors - therapeutic use (3) 3
ticlopidine - therapeutic use (3) 3
treatment failure (3) 3
aggregation (2) 2
angina (2) 2
angina pectoris (2) 2
angina, unstable - drug therapy (2) 2
anticoagulants (2) 2
association (2) 2
benzodiazepines - adverse effects (2) 2
benzodiazepines - therapeutic use (2) 2
biomarkers - blood (2) 2
bleeding (2) 2
blood pressure (2) 2
cardiovascular diseases - blood (2) 2
cardiovascular diseases - complications (2) 2
cardiovascular diseases - epidemiology (2) 2
cholesterol ester transfer proteins - antagonists & inhibitors (2) 2
cholesterol, hdl - blood (2) 2
clinical trials (2) 2
comparative analysis (2) 2
complications and side effects (2) 2
coronary angiography (2) 2
diabetes mellitus - drug therapy (2) 2
diagnosis (2) 2
disease prevention (2) 2
drug administration schedule (2) 2
enoxaparin (2) 2
fibrinolytic agents - therapeutic use (2) 2
heart diseases (2) 2
heart-disease (2) 2
hemorrhage (2) 2
human health and pathology (2) 2
hypercholesterolemia - drug therapy (2) 2
incidence (2) 2
intervention (2) 2
intracranial arteriosclerosis - drug therapy (2) 2
least-squares analysis (2) 2
life sciences (2) 2
medical imaging (2) 2
medicine (2) 2
mexico (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Stroke, 06/2019, Volume 50, Issue 6, pp. 1356 - 1363
Background and Purpose- Predictors of stroke and transient ischemic attack (TIA) in patients with peripheral artery disease (PAD) are poorly understood. The... 
clopidogrel | blood pressure | atrial fibrillation | risk factors | myocardial infarction
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 14, pp. 1297 - 1309
Journal Article
Journal Article
American Journal of Cardiovascular Drugs, ISSN 1175-3277, 2009, Volume 9, Issue 3, pp. 143 - 148
  Acute coronary syndromes (ACS) include unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial... 
Journal Article
Heart, ISSN 1355-6037, 08/2016, Volume 102, Issue 15, pp. 1221 - 1229
ObjectiveWe investigated whether prior clopidogrel influenced long-term ischaemic and bleeding risks and modified the randomised treatment effect of... 
INTERVENTION INSIGHTS | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | DIPHOSPHATE RECEPTOR INHIBITORS | MYOCARDIAL-INFARCTION | PLATELET INHIBITION | CONTEMPORARY PRACTICE | PRASUGREL | ST-SEGMENT ELEVATION | TRANSLATE-ACS | TRILOGY ACS TRIAL | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Aspirin - administration & dosage | Acute Coronary Syndrome - complications | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Prasugrel Hydrochloride - administration & dosage | Drug Therapy, Combination | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Hospitalization | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Stroke - etiology | Acute Coronary Syndrome - diagnosis | Aged | Hemorrhage - chemically induced | Complications and side effects | Ischemia | Clopidogrel | Dosage and administration | Acute coronary syndrome | Drug therapy | Comparative analysis | Hemorrhage | Risk factors | Aspirin | Stroke | Heart attacks | Statistical analysis | Blood platelets | Acute coronary syndromes | Drug dosages | Patients | Clinical outcomes
Journal Article
Circulation, ISSN 0009-7322, 12/2005, Volume 112, Issue 25, pp. 3846 - 3854
Background - Low-molecular-weight heparin (LMWH) offers pharmacological and practical advantages over unfractionated heparin (UFH). Whether these advantages... 
Myocardial infarction | Heparin | Angiography | Fibrinolysis | ENOXAPARIN | CARDIAC & CARDIOVASCULAR SYSTEMS | SEGMENT ELEVATION | myocardial infarction | RANDOMIZED CONTROLLED-TRIAL | ASPIRIN | angiography | heparin | fibrinolysis | INVASIVE STRATEGY | PERCUTANEOUS CORONARY INTERVENTION | PLASMINOGEN-ACTIVATOR | THROMBOLYSIS | PERIPHERAL VASCULAR DISEASE | REPERFUSION THERAPY | ANTITHROMBIN THERAPY | HEMATOLOGY | Myocardial Infarction - mortality | Ticlopidine - therapeutic use | Humans | Middle Aged | Heparin - administration & dosage | Male | Secondary Prevention | Fibrinolytic Agents - adverse effects | Fibrinolytic Agents - therapeutic use | Coronary Thrombosis - prevention & control | Electrocardiography | Adult | Female | Myocardial Infarction - physiopathology | Aspirin - therapeutic use | Heparin - toxicity | Drug Therapy, Combination | Heparin, Low-Molecular-Weight - toxicity | Treatment Outcome | Vascular Patency - drug effects | Ticlopidine - analogs & derivatives | Coronary Angiography | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Myocardial Reperfusion | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Fibrinolytic Agents/adverse effects/therapeutic use | Recurrence/prevention & control | Low-Molecular-Weight/administration & dosage/toxicity | MEDICIN OCH HÄLSOVETENSKAP | Combination | Myocardial Infarction/complications/drug | Ticlopidine/analogs & derivatives/therapeutic use | MEDICAL AND HEALTH SCIENCES | therapy/mortality/physiopathology | Vascular Patency/drug effects | Drug Therapy | Aspirin/therapeutic use | Hemorrhage/chemically induced | Heparin/administration & dosage/toxicity | Coronary Thrombosis/prevention & control
Journal Article
The New England journal of medicine, 05/2017, Volume 376, Issue 20, p. 1933
Journal Article